BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20388525)

  • 1. Pharmacological potential of RNAi--focus on miRNA.
    Pfeifer A; Lehmann H
    Pharmacol Ther; 2010 Jun; 126(3):217-27. PubMed ID: 20388525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
    Weiler J; Hunziker J; Hall J
    Gene Ther; 2006 Mar; 13(6):496-502. PubMed ID: 16195701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intron-mediated RNA interference, intronic microRNAs, and applications.
    Ying SY; Chang CP; Lin SL
    Methods Mol Biol; 2010; 629():205-37. PubMed ID: 20387152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not miR-ly small RNAs: big potential for microRNAs in therapy.
    Love TM; Moffett HF; Novina CD
    J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
    Paulson H
    Neurology; 2006 Jan; 66(2 Suppl 1):S114-7. PubMed ID: 16432138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transcriptional gene silencing by siRNAs and miRNAs.
    Filipowicz W; Jaskiewicz L; Kolb FA; Pillai RS
    Curr Opin Struct Biol; 2005 Jun; 15(3):331-41. PubMed ID: 15925505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illuminating the silence: understanding the structure and function of small RNAs.
    Rana TM
    Nat Rev Mol Cell Biol; 2007 Jan; 8(1):23-36. PubMed ID: 17183358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference in cancer.
    Gartel AL; Kandel ES
    Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro RNAs: tiny sequences with enormous potential.
    Shruti K; Shrey K; Vibha R
    Biochem Biophys Res Commun; 2011 Apr; 407(3):445-9. PubMed ID: 21419103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
    Federici T; Boulis NM
    Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of shRNAs for RNAi-A lesson from pre-miRNA processing: possible clinical applications.
    Pekarik V
    Brain Res Bull; 2005 Dec; 68(1-2):115-20. PubMed ID: 16325011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in MicroRNA targeting.
    Montgomery RL; van Rooij E
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases.
    Kolfschoten IG; Regazzi R
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):827-34. PubMed ID: 18026161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of expression vectors for RNA interference based on miRNAs and RNA splicing.
    Du G; Yonekubo J; Zeng Y; Osisami M; Frohman MA
    FEBS J; 2006 Dec; 273(23):5421-7. PubMed ID: 17076699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging world of microRNAs.
    O'Driscoll L
    Anticancer Res; 2006; 26(6B):4271-8. PubMed ID: 17201144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs--targeting and target prediction.
    Saito T; Saetrom P
    N Biotechnol; 2010 Jul; 27(3):243-9. PubMed ID: 20219708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives in intronic micro RNAs (miRNAs).
    Ying SY; Lin SL
    J Biomed Sci; 2006 Jan; 13(1):5-15. PubMed ID: 16228283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.